BLOOD & ONCOLOGY, HEMATOLOGY, LEUKEMIA, ONCOLOGY 2017 - 8th International Conference on Blood Cancer & Treatment
Website http://bloodmalignancies.conferenceseries.com/ |
Category Blood & Oncology; Hematology; Leukemia; Oncology
Deadline: June 26, 2017 | Date: June 26, 2017-June 27, 2017
Venue/Country: London, UK, U.K.
Updated: 2016-12-30 16:33:15 (GMT+9)
Call For Papers - CFP8th International Conference on Blood Cancer & Treatment Date: June 26-27, 2017Venue: London, UKConference Series LLC is glad to welcome all the interested participants to its 8th International Conference on Blood Cancer and Treatment during June 26-27, 2017 at London, UK. The conference will be organized around the theme “Inspiring Innovations and Interactive discussions on Blood Cancer”. Blood Cancer 2017 welcomes the haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.Blood Cancer 2017 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.Conference Series LLC which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Unique Features:• Our robust on-line publicity attracts 20000 users and 60000 views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences.• The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral FellowsAccepted Abstracts will be published in PubMed, MEDLINE, Pro Quest, SCOPUS, SOCOLAR, EBSCO, CAS, Hinari, Index Copernicus, Google Scholar, SCIRUS, DOAJ indexed journalsCertain benefits that you will avail as a Speaker: International Exposure to research work Abstract will be viewed by 30,000-40,000 viewers every year Live streaming of talk International speaker certificate Research work will be published in International Journals without any additional charges Networking and Collaborating opportunity with peer researchersConference Highlights• Blood Malignancies• Leukemia• Myeloma• Hematology• Myelodysplastic Syndrome• Myeloproliferative Neoplasms• Childhood Hematological Cancers• Blood Cancer: Causes & Symptoms• Blood Cancer: Diagnosis• Blood Cancer: Staging• Blood Cancer: Treatment and Care• Bone Marrow Transplantation• Leukocyte Biology• Immunology• Haematologic Oncology• Cancer Epidemiology• Hematological Malignancies: Prognosis• Cancer and Pharma Market• Oncology and Nursing• Blood Cancer: Other Aspects• Case Report• Entrepreneurs Investment MeetWhy to attend?This unique international conference provides a platform for researchers and decision makers in cancer research to present their latest findings and learn about all the important developments in cancer research. Many scientists and world's renowned experts will participate in the conference. Throughout the course of the three day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate cancer research communities.Target Audience• Oncologists• Radiologists• Pathologists• Hematologists• Academicians• Research Scholars• Students• Hematology Associations & Societies• Business Entrepreneurs• Software Developing Companies• Medical Devices Companies• Biomedical Companies• Biotechnology Companies• Data Management Companies
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.